Most bought healthcare stocks in Q1 2020

See which Healthcare stocks institutional investors increased the most in Q1 2020, measured as net growth in reported share positions from Q4 2019 into Q1 2020. Notable additions at the top of this list include AGILENT TECHNOLOGIES INC (A), BOSTON SCIENTIFIC CORP (BSX), CENTENE CORP (CNC), PRECIGEN INC (PGEN). These rankings aggregate SEC 13F filings from all institutional investors in our database.

Net change in reported shares (all institutional filers) by symbol20 symbols with net change in reported shares from all institutional filers.0.003.8M7.5M11.3M15.0MNet change in reported shares (all institutional filers)ABSXCNCPGENABTSDGRCERSMRKPACBBDXNVSTAMRNABBVHCAEXELXRAYEHCNVONTLATAKSymbol
SymbolNameNet sharesNet valueNewAddedTrimmedSold outHolding now
AAGILENT TECHNOLOGIES INC13,654,346$850.22M32208
BSXBOSTON SCIENTIFIC CORP9,095,610-$2.00M31226
CNCCENTENE CORP8,847,557$475.30M33117
PGENPRECIGEN INC8,345,086$28.37M30003
ABTABBOTT LABORATORIES8,148,549$547.65M346013
SDGRSCHRODINGER INC6,981,665$301.05M10001
CERSCERUS CORP4,560,330$25.27M01011
MRKMERCK & CO. INC.2,936,441$69.34M278020
PACBPACIFIC BIOSCIENCES OF CALIF2,683,645$4.74M01002
BDXBECTON DICKINSON AND CO2,602,564$266.39M435113
NVSTENVISTA HOLDINGS CORP2,456,573$20.04M20012
AMRNAMARIN CORP PLC -ADR2,370,355$8.60M11002
ABBVABBVIE INC2,298,999$23.63M335012
HCAHCA HEALTHCARE INC2,160,695$48.24M31105
EXELEXELIXIS INC2,153,218$29.90M11002
XRAYDENTSPLY SIRONA INC1,662,494-$105.96M22206
EHCENCOMPASS HEALTH CORP1,632,431$104.39M20103
NVONOVO-NORDISK A/S-SPONS ADR1,524,391$152.87M01011
NTLAINTELLIA THERAPEUTICS INC1,461,154-$3.55M01011
TAKTAKEDA PHARMACEUTIC-SP ADR1,426,280$1.13M01102
INCYINCYTE CORP1,373,760-$5.37M14005
MCRBSERES THERAPEUTICS INC1,334,871$5.77M01102
HUMHUMANA INC1,240,851$147.90M12124
PBYIPUMA BIOTECHNOLOGY INC994,013$8.36M11002
AUPHAURINIA PHARMACEUTICALS INC983,954$10.64M12003
HSICHENRY SCHEIN INC927,221$37.72M21104
EDITEDITAS MEDICINE INC886,242-$33.90M02103
HRTXHERON THERAPEUTICS INC870,892$8.10M01001
VXRTVAXART INC803,954$3.37M01001
WSTWEST PHARMACEUTICAL SERVICES757,198$116.36M20103
IRWDIRONWOOD PHARMACEUTICALS INC744,763$5.09M01001
MTNBMATINAS BIOPHARMA HOLDINGS I726,358-$61.00K01001
SNNSMITH & NEPHEW PLC -SPON ADR721,250$25.87M10001
OCGNOCUGEN INC675,514$187.00K01001
PCRXPACIRA BIOSCIENCES INC670,804$1.34M01001
GRFSGRIFOLS SA-ADR667,751-$27.18M01102
ALGNALIGN TECHNOLOGY INC656,989-$709.82M23237
ALKSALKERMES PLC653,731-$30.26M11002
SAGESAGE THERAPEUTICS INC636,541$13.47M01001
AMGNAMGEN INC630,543-$46.13M324011
ZBHZIMMER BIOMET HOLDINGS INC592,165-$19.11M23116
CTLTCATALENT INC574,005$22.62M02103
CPRXCATALYST PHARMACEUTICALS INC563,526$2.19M01001
ELANELANCO ANIMAL HEALTH INC554,759-$20.69M22004
OMIOWENS & MINOR INC538,250$14.85M01001
CORTCORCEPT THERAPEUTICS INC534,627$4.73M01001
ALDXALDEYRA THERAPEUTICS INC517,200$1.01M01001
THCTENET HEALTHCARE CORP511,200$6.69M01001
EXASEXACT SCIENCES CORP493,526-$42.65M21003
PSNLPERSONALIS INC478,209$2.09M01001

Frequently asked questions about Most bought healthcare stocks in Q1 2020

  • What are the most bought Healthcare stocks in Q1 2020?

    The most bought healthcare stocks in Q1 2020 are those with the largest increase in reported share counts across institutional investors compared to Q4 2019, based on SEC 13F filings.

  • Which healthcare stocks did institutional investors added to the most in Q1 2020?

    Among filers in this sector, net additions were largest in companies such as AGILENT TECHNOLOGIES INC (A), BOSTON SCIENTIFIC CORP (BSX), CENTENE CORP (CNC), based on aggregated 13F data.

  • How is institutional buying calculated?

    Buying is calculated by summing the net increase in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q4 2019).

  • Does this include all institutional owners?

    Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.

  • Are these trades real-time?

    No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.